A Pilot Study Using Placenta Derived Decidual Stromal Cells for Toxicity and Inflammation With Special Focus to the Allogeneic Hematopoietic Cell Transplantation Setting

NCT02175303 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Acute Lung Injury
Decidual Stromal Cells
Stem Cell Transplantation
Inflammation

Interventions

BIOLOGICAL: Decidual stromal cell therapy

Sponsor

Karolinska Institutet